The global biocatalysis market is expected to reach a high CAGR of 5.9% over the Forecast Period 2025-2032, from USD 7.9 billion in 2022 to USD 15.7 billion by 2032. Europe most certainly will dominate the market over the expected period.
Rising demand for ecologically friendly production procedures in a variety of industries is fuelling significant growth in the biocatalysis market. Biocatalysts, such as microorganisms and enzymes, provide numerous advantages over traditional chemical catalysts, including increased selectivity, efficiency, and less environmental effect. The pharmaceutical industry, in particular, is increasingly relying on biocatalysis to produce complex therapeutic molecules, hence contributing to market expansion.
Changing market trend toward sustainable production techniques and green chemistry
Green chemistry and sustainable manufacturing techniques are clearly taking front stage in the biocatalysis sector. Tight rules on chemical manufacture and growing environmental issues fuel this tendency. Being obtained from natural sources, biocatalysts provide a more sustainable alternative for conventional chemical catalysts. They lower energy use, permit reactions under less demanding circumstances, and help to decrease waste creation.
Biocatalytic techniques are being used by industries more and more to satisfy environmental targets and lower their impact. In the pharmaceutical, food and beverage, and textile sectors—where biocatalysis is being used to create cleaner, more effective manufacturing techniques—this trend is especially notable.
Increasing need in fine chemical and pharmaceutical sectors for biocatalysts
The biocatalyzes market is mainly driven by the increasing need for them in fine chemical and pharmaceutical sectors. In drug manufacturing, biocatalysts have various benefits including great selectivity, low reaction conditions, and the capacity to catalyze complicated processes. Crucially in pharmaceutical manufacture, they help to produce chiral molecules with great purity. Adoption of biocatalysis is driven by growing attention on creating more sustainable and effective medication manufacturing techniques.
Furthermore increasing the usage of biocatalysts for their synthesis are the growing need for specialized and fine compounds in many sectors. Biocatalysts are appealing for synthesis of high-value compounds because they may carry highly precise reactions while lowering environmental effect.
High expenses related to enzyme manufacture and development
The biocatalysis market is much limited by the great expenses related to enzyme development and manufacturing. Research & development must be heavily invested in order to create novel enzymes or maximize current ones for particular industrial use. Often time-consuming and costly, the procedure calls for modern technologies like directed evolution and protein engineering. Moreover, manufacturing enzymes on industrial levels may be expensive, especially for highly specialized or extremely pure ones. Particularly in price-sensitive sectors or for extensive uses, these high prices might restrict the acceptance of biocatalysis.
Further raising general expenses are the volatility of certain enzymes and the need of particular reaction conditions, which may call for further expenditures in process development and control systems.
By kind, hydrolases dominate the biocatalysis market
With a noteworthy market share, hydrolases are the most often employed enzyme in biocatalysis. By catalyzing hydrolysis events, these enzymes simplify complicated molecules into simpler ones. Food and beverage, medicines, and biofuel manufacture are just a few of the many sectors where hydrolases find great uses. Their adaptability and effectiveness in catalyzing a broad spectrum of reactions make them indispensable in many industrial processes, hence pushing their predominance in the biocatalysis industry.
Strong pharmaceutical and biotechnology industries help Europe dominate the biocatalysis industry.
Driven by its strong pharmaceutical and biotechnology sectors, Europe dominates the worldwide biocatalysis industry. Strong environmental rules and a concentration on sustainable manufacturing techniques in the area have hastened the acceptance of biocatalysis in many different fields. Particularly Germany, Switzerland, and the UK, European nations host a large number of pharmaceutical businesses and research facilities actively involved in biocatalysis study and development.
Leading manufacturers of enzymes and a developed industrial biotechnology industry help to explain Europe's market supremacy even further. Government programs supporting sustainable chemistry and bio-based businesses have also helped to establish a suitable environment for the development of biocatalysis in the area.
Strong rivalry among important players including chemical corporations, biotechnology businesses, and enzyme makers defines the biocatalysis industry. To improve enzyme performance and increase their product range, big corporations are giving research and development top priority. Common approaches to improve market positions and acquire fresh innovations include strategic alliances, mergers, and acquisitions.
Businesses are also making investments in increasing manufacturing capacity to satisfy the rising demand for biocatalysts in many different sectors. To provide customised biocatalytic solutions, the industry is seeing growing alliances between end-user sectors and enzyme manufacturers. Companies are stressing the creation of more effective and environmentally friendly biocatalysts to get a competitive advantage as sustainability takes front stage.
Major Players Key Players:
1. Novozymes A/S
2. BASF SE
3. DuPont de Nemours, Inc.
4. Codexis, Inc.
5. Biocatalysts Ltd.
6. Enzymes Inc.
7. Amano Enzyme Inc.
8. Royal DSM N.V.
9. Lonza Group Ltd.
10. AB Enzymes GmbH
11. Evocatal GmbH
12. Johnson Matthey PLC
1. INTRODUCTION
1.1. Market Definition
1.2. Study Scope
1.3. Currency Conversion
1.4. Study Period (2025-2032)
1.5. Regional Coverage
2. RESEARCH METHODOLOGY
2.1. Primary Research
2.2. Secondary Research
2.3. Company Share Analysis
2.4. Data Triangulation
3. EXECUTIVE SUMMARY
3.1. Global Biocatalysis Market (2025 – 2032)
3.2. Global Biocatalysis Market (2025 – 2032)
3.2.1. Market Segment By Type (2025 – 2032)
3.2.2. Market Segment By Application (2025 – 2032)
3.2.3. Market Segment By Form (2025 – 2032)
3.2.4. Market Segment By End-user (2025 – 2032)
4. MARKET DYNAMICS
4.1. Market Trends
4.1.1. Shift towards green chemistry and sustainable manufacturing processes
4.2.2. Increasing adoption of enzyme engineering techniques
4.2.3. Growing focus on bio-based materials and chemicals
4.2. Market Drivers
4.2.1. Growing demand for biocatalysts in pharmaceutical and fine chemical industries
4.2.2. Rising awareness of environmental sustainability
4.2.3. Advancements in biotechnology and enzyme engineering
4.3. Market Restraints
4.3.1. High costs associated with enzyme development and production
4.3.2. Limited stability and reusability of some biocatalysts
4.4. Porter's Five Forces Analysis
4.4.1. Threat of New Entrants
4.4.2. Bargaining Power of Buyers/Consumers
4.4.3. Bargaining Power of Suppliers
4.4.4. Threat of Substitute Products
4.4.5. Intensity of Competitive Rivalry
4.5. Supply Chain Analysis
4.6. Pricing Analysis
4.7. Regulatory Analysis
4.8. Pipeline Analysis
5. BY TYPE (MARKET VALUE (US$ MILLION) – 2025-2032*)
5.1. Hydrolases
5.2. Oxidoreductases
5.3. Transferases
5.4. Others
6. BY APPLICATION
6.1. Food & Beverages
6.2. Pharmaceuticals
6.3. Biofuel Production
6.4. Textile Industry
7. BY FORM
7.1. Powder
7.2. Liquid
8. BY END-USER
8.1. Industrial
8.2. Research & Development
9. GEOGRAPHY
9.1. North America
9.1.1. United States
9.1.2. Canada
9.1.3. Mexico
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Rest of South America
9.3. Europe
9.3.1. Germany
9.3.2. United Kingdom
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle-East
9.5.1. UAE
9.5.2. Saudi Arabia
9.5.3. Turkey
9.5.4. Rest of Middle East
9.6. Africa
9.6.1. South Africa
9.6.2. Egypt
9.6.3. Rest of Africa
10. COMPETITIVE LANDSCAPE
10.1. Key Developments
10.2. Company Market Share Analysis
10.3. Product Benchmarking
11. SWOT ANALYSIS
12. COMPANY PROFILES
12.1. Novozymes A/S
12.2. BASF SE
12.3. DuPont de Nemours, Inc.
12.4. Codexis, Inc.
12.5. Biocatalysts Ltd.
12.6. Enzymes Inc.
12.7. Amano Enzyme Inc.
12.8. Royal DSM N.V.
12.9. Lonza Group Ltd.
12.10. AB Enzymes GmbH
12.11. Evocatal GmbH
12.12. Johnson Matthey PLC
13. MARKET OPPORTUNITIES
By Type:
Hydrolases
Oxidoreductases
Transferases
Others
By Application:
Food & Beverages
Pharmaceuticals
Biofuel Production
Textile Industry
By Form:
Powder
Liquid
By End-user:
Industrial
Research & Development
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511